Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2020

 We would like to inform you that, Board Meeting of the Company was held today i.e. on Wednesday, October 21, 2020 at the registered office of the Company. In pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith. Kindly take the above information on your record and acknowledge.
21-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Shareholding for the Period Ended September 30, 2020

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
21-10-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of newspaper advertisement of notice published in The Free Press Journal (English) and Navshakti (Regional) on October 19, 2020, concerning the proposed transfer of unclaimed final dividend 2012-2013 and its corresponding shares to IEPF Authority, pursuant to Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time.
19-10-2020
Bigul

Bliss GVS Pharma Ltd - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2012-2013 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority

 In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copy of the communication issued to those concerned shareholders, whose dividend have been remain unclaimed for the period of seven consecutive years or more, concerning the proposed transfer of unclaimed final dividend 2012-2013 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
19-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020

 Please find enclosed herewith certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2020. Kindly take the same on record.
17-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer
14-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company scheduled to be held on Wednesday, October 21, 2020 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshakti' a Regional Daily, on October 14, 2020. Kindly take the same on record.
14-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020. Kindly take the same on record.
14-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2020

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board Meeting of the Company will be held on Wednesday, October 21, 2020 at the registered office of the Company, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020.
13-10-2020
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
08-10-2020
Next Page
Close

Let's Open Free Demat Account